Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy IRIDEX Corporation stock | $2.51

Own IRIDEX Corporation stock in just a few minutes.

Fact checked

IRIDEX Corporation is a medical devices business based in the US. IRIDEX Corporation shares (IRIX) are listed on the NASDAQ and all prices are listed in US Dollars. IRIDEX Corporation employs 94 staff and has a trailing 12-month revenue of around USD$35.8 million.

How to buy shares in IRIDEX Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for IRIDEX Corporation. Find the stock by name or ticker symbol: IRIX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until IRIDEX Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$2.51, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of IRIDEX Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of IRIDEX Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

IRIDEX Corporation share price

Use our graph to track the performance of IRIX stocks over time.

IRIDEX Corporation shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$2.51
52-week rangeUSD$1.22 - USD$4.24
50-day moving average USD$1.7773
200-day moving average USD$1.9742
Wall St. target priceUSD$4.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.864

Buy IRIDEX Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy IRIDEX Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IRIDEX Corporation price performance over time

Historical closes compared with the close of $2.51 from 2020-12-31

1 week (2021-01-08) -5.28%
1 month (2020-12-16) 49.40%
3 months (2020-10-16) 27.35%
6 months (2020-07-16) 23.65%
1 year (2020-01-16) -27.03%
2 years (2019-01-16) -49.40%
3 years (2018-01-16) 7.88
5 years (2016-01-15) 9.4

IRIDEX Corporation financials

Revenue TTM USD$35.8 million
Gross profit TTM USD$17.9 million
Return on assets TTM -15.33%
Return on equity TTM -37.4%
Profit margin -21.54%
Book value $1.241
Market capitalisation USD$27 million

TTM: trailing 12 months

Shorting IRIDEX Corporation shares

There are currently 182,478 IRIDEX Corporation shares held short by investors – that's known as IRIDEX Corporation's "short interest". This figure is 12.4% down from 208,238 last month.

There are a few different ways that this level of interest in shorting IRIDEX Corporation shares can be evaluated.

IRIDEX Corporation's "short interest ratio" (SIR)

IRIDEX Corporation's "short interest ratio" (SIR) is the quantity of IRIDEX Corporation shares currently shorted divided by the average quantity of IRIDEX Corporation shares traded daily (recently around 141455.81395349). IRIDEX Corporation's SIR currently stands at 1.29. In other words for every 100,000 IRIDEX Corporation shares traded daily on the market, roughly 1290 shares are currently held short.

However IRIDEX Corporation's short interest can also be evaluated against the total number of IRIDEX Corporation shares, or, against the total number of tradable IRIDEX Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IRIDEX Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 IRIDEX Corporation shares in existence, roughly 10 shares are currently held short) or 0.0144% of the tradable shares (for every 100,000 tradable IRIDEX Corporation shares, roughly 14 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against IRIDEX Corporation.

Find out more about how you can short IRIDEX Corporation stock.

IRIDEX Corporation share dividends

We're not expecting IRIDEX Corporation to pay a dividend over the next 12 months.

IRIDEX Corporation share price volatility

Over the last 12 months, IRIDEX Corporation's shares have ranged in value from as little as $1.22 up to $4.24. A popular way to gauge a stock's volatility is its "beta".

IRIX.US volatility(beta: 1.09)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IRIDEX Corporation's is 1.0866. This would suggest that IRIDEX Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

IRIDEX Corporation overview

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system that delivers laser to treat glaucoma; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site